Evaluating the occurrence of increased postoperative cardiac enzymes in patients with coronary atherosclerotic obstruction.
Sign Up to like & getrecommendations! Published in 2022 at "Cellular and molecular biology"
DOI: 10.14715/cmb/2022.68.1.16
Abstract: Percutaneous transluminal coronary angioplasty (PTCA) has been accepted as the elective treatment in many patients with coronary atherosclerotic obstruction. A slight increase in cardiac markers after the percutaneous coronary intervention (PCI) has been commonly reported.… read more here.
Keywords: atherosclerotic obstruction; occurrence increased; coronary atherosclerotic; patients coronary ... See more keywords